Carlo Buonerba

Plain English
This study examined the levels of copper, rubidium, selenium, strontium, and zinc in the blood of adults aged 30-65 from the Sarno River Basin in Italy, exploring their connections to mental and physical health. It found that higher levels of zinc and rubidium were linked to lower chances of severe fatigue, with zinc reducing the odds by 62% and rubidium by 67%. Additionally, higher strontium levels were associated with better overall well-being. Who this helps: This research benefits patients dealing with fatigue and mental health issues.

Plain English
This study looked at treatment options for patients with muscle-invasive bladder cancer who cannot receive the standard cisplatin chemotherapy. Researchers found promising results with two new treatment approaches: one using enfortumab vedotin plus pembrolizumab, which showed effective responses in trials, and another using TAR-200, an intravesical treatment combined with immune therapy. These findings are important because they offer hope for effective treatments for patients who are ineligible for cisplatin, addressing a significant gap in cancer care. Who this helps: Patients with muscle-invasive bladder cancer who cannot receive cisplatin due to health issues.

Plain English
This study explored how dietary habits might affect the chances of bladder cancer returning after treatment with BCG therapy in patients at high risk for recurrence. Out of 41 patients monitored, 8 experienced a recurrence within one year, which is 19.5%. While they found some potential links between eating more leafy greens, zinc, and magnesium and lower recurrence rates, these findings weren't strong enough to be conclusive. Who this helps: This research can help patients with non-muscle-invasive bladder cancer and their doctors understand the potential impact of diet on treatment outcomes.

Plain English
This study looked at how hormone therapy for prostate cancer affects the quality of life for patients. Researchers found that, after six months of treatment, men's physical abilities decreased significantly, their fatigue and insomnia increased, and their sexual function dropped dramatically from an average score of 59 to 26.9. These findings highlight the need for healthcare providers to consider both the physical and emotional needs of men undergoing this treatment to improve their overall well-being. Who this helps: This helps patients with prostate cancer and their doctors.

Plain English
This study focused on creating and testing a new tool called the REST Questionnaire to measure fatigue levels in people, both with and without a history of cancer. Researchers examined 268 adults and found that the REST Questionnaire effectively assesses different aspects of fatigue, showing a strong reliability (with a score of 0.918) and clear links between higher fatigue levels and lower well-being, as well as certain chronic health issues. This matters because it provides a comprehensive way to understand fatigue that can help improve health interventions and support for those affected. Who this helps: This benefits patients experiencing fatigue, healthcare providers, and researchers working in public health.

Plain English
This study looked at the effects of environmental pollution on people's health in the Sarno River Basin in southern Italy by testing three new tools to measure fatigue, mood, and sleep quality. They found that these tools are reliable in assessing these issues, and participants who received a health supplement reported significant improvements: fatigue levels dropped by 12.5 points, mood improved by 13 points, and sleep quality increased by 1.5 points. These findings are important because they can help improve public health responses and measure the effects of environmental clean-ups. Who this helps: Patients living in polluted areas who struggle with fatigue, depression, and sleep issues.

Plain English
This study created and tested a new questionnaire called PREVESMED, which measures how well people follow the Mediterranean lifestyle known for helping reduce chronic diseases. With data from 268 participants, the tool was found to reliably assess lifestyle habits, showing that exercise, using olive oil, and eating fruits and vegetables were strongly linked to better adherence, while daily alcohol intake had a weaker connection. This is important because understanding and improving lifestyle choices can lead to better health outcomes for individuals. Who this helps: Patients looking to improve their health through lifestyle changes.

Plain English
This study examined whether the ratio of platelets to lymphocytes in the blood before surgery (called the platelet-to-lymphocyte ratio, or PLR) can predict if penile cancer has spread to lymph nodes. Out of 60 patients, 36 (60%) had confirmed lymph node spread, while 24 (40%) did not. A PLR higher than 122.4 was found to be a significant indicator of lymph node involvement, meaning this measure could help doctors identify patients at higher risk for this spread before surgery. Who this helps: This helps doctors in managing treatment plans for patients with penile cancer.

Plain English
This study looks at a rare type of cancer called leiomyosarcoma that can occur in the ureter, which is the tube that carries urine from the kidney to the bladder. The researchers reported on a 59-year-old woman who had abdominal pain and was found to have a tumor measuring 45 by 52 millimeters in her ureter. After surgery to remove the tumor, it was confirmed to be leiomyosarcoma, highlighting the need to consider this rare cancer when diagnosing ureter issues. Who this helps: This information helps doctors and patients by raising awareness of rare tumors in the urinary tract.

Plain English
This study looked at how dietary supplements affect breast cancer patients, particularly their quality of life and treatment side effects. They reviewed 45 studies and found that vitamin D, omega-3 fatty acids, and beta-glucan might help improve symptoms and quality of life, though results were mixed for other supplements. These findings are important because they point to ways that supplements might support breast cancer treatment, but more research is needed to confirm the best options. Who this helps: Breast cancer patients looking for ways to improve their treatment experience.

Plain English
This study looked at the levels of lead and cadmium in the blood of 75 adults from the polluted Sarno river basin in Italy. It found that 18.67% of participants had detectable lead, which was linked to higher blood pressure and poorer sleep quality, while 28% had detectable cadmium, associated with higher blood pressure and a greater likelihood of autoimmune diseases. These findings highlight the health risks posed by environmental pollution and emphasize the importance of ongoing health assessments in affected communities. Who this helps: This helps residents in polluted areas, healthcare providers, and public health officials.

Plain English
This study looked at how being immunocompromised affects the chances of bladder cancer coming back or worsening in patients treated with BCG therapy, a common treatment for non-muscle invasive bladder cancer. It found that immunocompromised patients had a 23% higher risk of disease progression and a 13% higher risk of recurrence compared to those with normal immune systems. While BCG treatment is generally safe for these patients, it might not be as effective, suggesting that doctors should consider more aggressive treatment options for them. Who this helps: This helps doctors and immunocompromised patients dealing with bladder cancer.

Plain English
This study focused on creating and testing a new questionnaire called the PREVES-HOR, designed to measure how hormone therapy affects the quality of life for men with prostate cancer receiving androgen deprivation therapy (ADT). From a group of 145 patients, the questionnaire showed strong reliability and identified six key areas affected by therapy, including physical fatigue, emotional well-being, and sexual health. The findings indicate that PREVES-HOR can effectively capture patient experiences that traditional questionnaires often miss, which is important for improving patient care and tailoring support during treatment. Who this helps: This benefits prostate cancer patients undergoing hormone therapy and their healthcare providers.

Plain English
This study looked at how well cemiplimab works for elderly patients with squamous cell carcinoma (SCC) of the skin. Out of 50 patients treated, 42% had a positive response to the drug, and on average, patients lived without their cancer worsening for about 20.8 months. The treatment was generally safe, with few side effects, which is important for managing this type of cancer in older adults. Who this helps: This benefits elderly patients with squamous cell carcinoma and their doctors.

Plain English
This study looked at how quickly patients with high-risk nonmuscle invasive bladder cancer progress to a more serious form of cancer and how that affects their overall survival. Out of 1,510 patients, 32.1% experienced progression within a median of 82 months, and 10.8% died during the study period. The researchers found that a shorter time to progression strongly predicted longer survival, suggesting that monitoring this progression could improve treatment and trial designs. Who this helps: This helps patients with bladder cancer and their doctors.

Plain English
This study looked at how diet, supplements, and lifestyle choices might affect bladder cancer risk and treatment outcomes, particularly with immunotherapy. The BLOSSOM study is currently examining these connections in patients with non-muscle-invasive bladder cancer to see if certain diets can enhance the effectiveness of their treatments. Understanding this relationship could lead to better management strategies for bladder cancer patients. Who this helps: Patients with bladder cancer and their healthcare providers.

Plain English
This study looked at how male, transgender, and gender-diverse individuals are included in clinical trials for breast cancer treatments. Out of 51 trials, only 35.3% allowed men to enroll, with only 112 men participating, which is just 0.2% of the total 77,409 patients. This is important because it shows that gender minorities are largely overlooked in breast cancer research, which can affect their access to effective treatments. Who this helps: This benefits gender minority patients with breast cancer.

Plain English
This study looked at how a specific blood test, the albumin-to-alkaline phosphatase ratio (AAPR), can predict whether patients with penile cancer will have cancer spread to their lymph nodes before they undergo surgery. Researchers found that a lower AAPR (0.53 or less) indicates a higher risk of lymph node involvement, with an odds ratio showing over a threefold increase in risk (OR = 3.61). Understanding this could help doctors identify high-risk patients and improve treatment planning. Who this helps: This helps patients with penile cancer and their doctors by providing better information for treatment decisions.

Plain English
This study looks at a new treatment strategy for a specific type of breast cancer that is both low in HER2 and hormone receptor-positive. Researchers are testing a drug called trastuzumab deruxtecan (T-DXd) on its own and in combination with endocrine therapy (letrozole) to see how well it works in treating this kind of breast cancer before surgery. They will measure how many patients have no signs of cancer after treatment and examine additional factors like safety and survival rates, aiming to reduce the need for traditional chemotherapy. Who this helps: This benefits patients with HER2-low, ER-positive breast cancer by potentially offering more effective and less harmful treatment options.

Plain English
This study looked at how taking flavonoid supplements affects levels of oxidative stress in healthy people aged 45-65. Researchers found that after two weeks of taking the supplements, participants had lowered their glucose levels from 82 to 74.5 mg/dL, decreased oxidative stress from 394.5 to 365.5 U.CARR, and reduced their systolic blood pressure from 133 to 122 mmHg, with most participants reporting no side effects. These findings are important because they suggest that flavonoid supplements could help lower health risks associated with chronic diseases as we age. Who this helps: Patients looking to reduce their risk of chronic diseases.

Plain English
Researchers studied how quercetin, a natural compound, combined with mafosfamide (MFA), a cancer drug, affects bladder cancer cells. They found that when both treatments were used together, they significantly reduced the cancer cells' growth; specifically, in certain cells, the combination caused more cell death than either treatment alone. This matters because bladder cancer is often hard to treat, and finding effective combinations could improve outcomes for patients. Who this helps: This helps patients with bladder cancer seeking better treatment options.

Plain English
The PREVES study looked at the lifestyle and dietary habits of 8,000 people in Salerno, Italy, to see how these factors relate to cancer. They found that 8.7% of participants had a history of cancer, with 30.5% being current smokers and 78.8% not exercising. Interestingly, those who never ate fruits and vegetables were five times more likely to have had colorectal cancer. This research highlights the importance of diet and lifestyle in cancer prevention and suggests that better healthcare strategies can help address these issues. Who this helps: This helps patients, healthcare providers, and public health policymakers.

Plain English
This study looked at the heart-related side effects experienced by cancer patients receiving two types of cancer treatments: a combination of anti-VEGF (vascular endothelial growth factor) agents and immune checkpoint inhibitors (ICIs) versus anti-VEGF agents alone. The researchers found that patients taking both treatments had a higher risk of cardiovascular problems, but the specific increase wasn't detailed in the summary. Understanding these risks is important because it helps doctors better weigh the benefits and harms of these cancer treatments in their patients. Who this helps: This helps doctors and cancer patients by informing them about potential heart risks associated with certain treatments.

Plain English
The study examined how certain factors influence the effectiveness of immune checkpoint inhibitors (ICIs) in patients with advanced bladder cancer. It analyzed data from 6,524 patients and found that those without certain types of metastasis and those with high levels of a specific protein (PDL-1) had a lower risk of dying. These findings are important because they can help doctors identify which patients are likely to benefit most from this type of treatment. Who this helps: This helps patients with advanced bladder cancer and their doctors make informed treatment decisions.

Plain English
This study looked at a rare type of skin cancer called squamous cell carcinoma, which occurs in the nasal vestibule, in an 83-year-old woman who couldn’t have surgery or radiation. She received treatment with a drug called cemiplimab and showed significant improvement in her tumor with no side effects. This matters because it shows cemiplimab may be an effective option for patients with this type of cancer who cannot undergo typical treatments. Who this helps: Patients with nasal vestibule squamous cell carcinoma, especially those unable to have surgery or radiation.

Plain English
This study examined the effectiveness of routine COVID-19 testing for cancer patients receiving treatment in a hospital. Researchers found that among 1,161 patients screened, 71 tested positive for COVID-19 without showing symptoms, while five tested positive outside the screenings. Those who were diagnosed through routine testing had a significantly lower chance of severe outcomes, such as needing hospitalization or dying from COVID-19, highlighting that regular screening can help protect vulnerable cancer patients. Who this helps: This helps cancer patients and their doctors by reducing the risk of severe COVID-19 outcomes.

Plain English
This study looked at bladder cancer, the most common type of urinary tract cancer, and explored a new method called liquid biopsy, which involves analyzing urine for cancer markers instead of using invasive procedures like cystoscopy. The findings suggest that liquid biopsy could provide a safer and more comfortable way to detect and monitor bladder cancer, addressing the pain and complications associated with current methods. This matters because it could lead to better patient care and easier follow-ups after diagnosis. Who this helps: This benefits patients with bladder cancer and their doctors.

Plain English
This study looked at the use of neoadjuvant systemic therapy (NAST), which includes chemotherapy and immunotherapy, in patients with upper tract urothelial cancer (UTUC) who are undergoing major surgery to remove the kidney and ureter. The researchers reviewed 27 studies and found that patients who received neoadjuvant chemotherapy before surgery had better survival rates and positive tumor responses compared to those who had surgery alone. However, there was no significant advantage over those who had surgery followed by additional treatments, and the overall evidence is still considered weak due to various study limitations. Who this helps: This information benefits patients with upper tract urothelial cancer and their doctors in making treatment decisions.

Plain English
The COICA study looked at how COVID-19 affected cancer patients and compared the outcomes between those who were vaccinated and those who were not. Out of 141 cancer patients, about 35% were vaccinated; the vaccinated patients had much better outcomes—none developed pneumonia or died, compared to almost 49% of unvaccinated patients who had pneumonia and about 8% who died. Vaccinated patients also cleared the virus faster, taking about 12 days compared to 20 days for unvaccinated patients. Who this helps: This research benefits cancer patients by highlighting the importance of vaccination against COVID-19.

Plain English
This study looked at how the Mediterranean diet might help cancer patients. Researchers found that following this diet, which includes plenty of fruits, vegetables, whole grains, and healthy fats, can improve patients' overall health and quality of life during treatment. Specifically, some studies reported that patients who adhered to this diet experienced better energy levels and reduced side effects from cancer therapies. Who this helps: This benefits cancer patients seeking ways to improve their health during treatment.

Plain English
This study looked at whether blood samples could be used to develop an easy way to screen for colorectal cancer (CRC), which is difficult to detect early. Researchers analyzed blood from 100 people with CRC, 50 healthy people, and 50 with benign conditions, and found that their method accurately identified all CRC cases 100% of the time. This is important because it offers a non-invasive alternative to current screening methods like colonoscopy, potentially leading to earlier and easier detection of cancer. Who this helps: This benefits patients at risk of colorectal cancer by providing a simpler screening option.

Plain English
This study looked at whether saliva is a reliable sample for detecting the COVID-19 virus in large community testing programs. Researchers tested 1,221 samples of saliva and nasal swabs and found that saliva matched the results of the nasal swabs 95.82% of the time, proving it can be a good alternative for testing, even catching virus presence when nasal swabs showed negative results. This is important because using saliva for testing could make it easier and safer to test more people for COVID-19. Who this helps: This benefits patients and public health officials conducting community health screenings.

Plain English
This study looked at rare genetic variations in certain genes related to the immune system that could protect elderly people from showing symptoms of COVID-19. The researchers found that 164 asymptomatic elderly individuals had more of these protective genetic variations in three specific genes (MASP1, COLEC11, and COLEC10) compared to almost 57,000 other people, suggesting that these variations help reduce the likelihood of developing severe disease. Understanding these genetic factors is important because they could lead to better prevention strategies and treatments for COVID-19, especially in vulnerable populations. Who this helps: This helps patients, particularly elderly individuals, by identifying genetic factors that may protect them from severe COVID-19.

Plain English
This research studied how pollution affects health in vulnerable communities, particularly in the Campania region of Italy, known as the "Land of Fires," where environmental contamination is a concern. The study involved over 4,200 residents and aimed to connect pollution sources to health impacts using a new comprehensive approach that combines data from various scientific fields. The findings are significant because they help identify health risks associated with pollution, guiding public health actions to protect affected communities. Who this helps: This helps patients and communities living near polluted areas.

Plain English
This study looked at a protein called FSCN1 in the blood of prostate cancer patients compared to those without cancer. The researchers found that the levels of FSCN1 were similar between the two groups (6.90 ng/ml for cancer patients versus 7.33 ng/ml for those without, with no significant difference). The findings indicate that more research is needed to see if FSCN1 can be used as a reliable test for prostate cancer. Who this helps: This helps researchers and doctors who are looking for new ways to diagnose prostate cancer.

Plain English
This research looked at the effects of three natural compounds—kaempferol, myricetin, and fisetin—on prostate and bladder cancer. Out of a review of various studies, they found enough evidence to suggest these compounds may help fight cancer, with kaempferol having the most research behind it (21 studies), while myricetin had the least (7 studies). This matters because using these compounds could be a low-risk way to help prevent or treat these cancers, suggesting a need for further clinical trials. Who this helps: This helps patients at risk for or suffering from prostate and bladder cancer.

Plain English
This study looked at how long people in Ariano Irpino, Italy, maintained antibodies against the virus that causes COVID-19 after being infected. Researchers found that over 90% of the people who were never sick still had detectable antibodies 11.5 months after infection, with no cases of re-infection noted. Understanding how long these immune responses last is important for planning vaccinations and public health strategies. Who this helps: This helps patients and public health officials.